Chronicle Journal: Finance

Markets
Stocks
Funds
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Recent Quotes
My Watchlist
Indicators
Biogen, Inc. (NQ: BIIB)
305.71 USD  +28.05 (+10.10%)
Official Closing Price  /  Updated: 7:59 PM EDT, Aug 7, 2020  /  Add to My Watchlist      
View: Quote News Research
Price and Volume
Detailed Quote
Chart for (: )
 
Intraday
1 Week
1 Month
3 Month
1 Year
  
Compare to:
Volume 4,454,600
Open 311.14
Bid (Size) 304.50 (1)
Ask (Size) 307.00 (3)
Prev. Close 277.66
Today's Range 299.29 - 312.00
52wk Range 215.77 - 374.99
Shares Outstanding 211,007,945
Dividend Yield N/A
Performance
YTD
+3.90%
+3.90%
1 Month
+9.11%
+9.11%
3 Month
-2.65%
-2.65%
6 Month
-9.74%
-9.74%
1 Year
+28.33%
+28.33%
Top News
More News
FDA Accepts Biogen’s Aducanumab Biologics License Application for Alzheimer's Disease with Priority Review
from GlobeNewswire News Releases
Biogen and Denali to Collaborate on LRRK2 Program for Parkinson’s Disease and Certain TV Platform-Enabled Programs for Neurodegenerative Diseases
from GlobeNewswire News Releases
More News
Read More
'Fast Money' Picks For August 10
category SONO , Market News , BIIB , and 10 more.
from Benzinga
Inspiring the Next Generation of Scientists in a New Way
category Community Involvement , Biogen , Biogen/MIT Biotech in Action: Virtual Summer Lab , and 9 more.
from 3BL Media: Corporate Social Responsibility, Energy and Health News
Week in Review: BioKangtai Acquires China Rights to AstraZeneca's COVID-19 Vaccine
from ChinaBio® Today
Week In Review: BioKangtai Acquires China Rights To AstraZeneca's COVID-19 Vaccine
category Healthcare , Pharma/Biotech , Stocks / Equities
from Blogs - TalkMarkets
Notable Friday Option Activity: BIIB, FDX, AAP
category Stocks
from Market News Video
BIIB Crosses Above Key Moving Average Level
category Stocks
from Market News Video
FDA Approves First Oral Treatment for Spinal Muscular Atrophy
category RHHB/Y , NVS , PTCT , and 2 more.
from Motley Fool
Biogen Soars As FDA Accepts Alzheimer's Drug For Review In 'Next Stage Of Aducanumab Saga'
category Top Stories , Analyst Color , Movers , and 13 more.
from Benzinga
Biogen Stock Surges As FDA Fast-Tracks Alzheimer's Drug Application
from Investor's Business Daily
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Six Financial & Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.

© Copyright 2015, Chronicle Journal, Thunder Bay, ON. Powered by BLOX Content Management System from TownNews.com. [Terms of Use | Privacy Policy]